期刊文献+

DWI对非小细胞肺癌放化疗疗效的评价 被引量:7

Diffusion-Weighted Imaging for the Evaluation of Chemoradiotherapy in Treating Non-Small-Cell Lung Cancers
原文传递
导出
摘要 目的探讨MRI扩散加权成像(DWI)在评价非小细胞肺癌(NSCLC)放化疗疗效中的价值。方法选择40例经病理证实为NSCLC并首次接受放化疗的患者,在治疗前1周内、治疗后1周和治疗后1个月3个时间点进行MRI-DWI扫描,并测量表观扩散系数(ADC)值。根据治疗结束后肿块最大径改变将病例分为有效组和无效组。应用独立样本t检验分析放化疗前有效组和无效组ADC值差异;治疗前后ADC值变化情况应用单因素方差分析法;两组放化疗后ADC值的变化率与肿瘤缩小率的相关性采用Pearson相关系数回归分析法。结果有效组和无效组治疗后2期ADC值均上升,有效组ADC值前后差异具有统计学意义(P<0.01),治疗后1周和1个月ADC值差异不具统计学意义;有效组和无效组治疗后1周ADC变化差异亦有统计学意义(P<0.05),选择治疗第1周ADC值变化12.5%用来监测疗效的敏感性90.9%和特异性63.4%均较高;化疗前两组ADC值存在差异(P<0.05),且疗前ADC值与肿瘤缩小率呈轻度负相关,化疗前后ADC值增大率与肿瘤缩小率存在正相关。结论 DWI在评价肺癌疗效中具有一定的临床价值,ADC值的变化可监测NSCLC的早期疗效。 Objective To investigate the clinical value of diffusion-weighted imaging( DWI) in assessing the therapeutic effect of chemoradiotherapy for non-small-cell lung cancer( NSCLC). Methods A total of 40 patients with pathologically-proved NSCLC were enrolled in this study. MRI DWI scanning was performed in all patients each time at one week before treatment and one week,one month after the treatment. ADC values of the tumors were calculated on the workstation. According to the change of the tumor's maximal diameter after the treatment,the patients were divided into two groups: effective group and invalid group. The pretreatment ADC values were compared between the two groups by using independent-samples t test,and variance analysis was used to compare pre-treatment ADC values with post-treatment values.Pearson correlation coefficient regression analysis was applied to analyze the relevance between the post-treatment ADC values and the reduction in tumor size. Results Post-treatment ADC values of both groups were increased. In the effective group,statistically significant difference in ADC values existed between the preoperative values and postoperative ones( P 〈0. 01),although the difference in ADC values was not statistically significant between one week and one month after the treatment. One week after the treatment the difference in ADC values between effective and invalid group was statistically significant( P〈 0. 05). Using 12. 5% change of ADC value at one week after the treatment to evaluate the therapeutic effect,both the sensitivity and specificity were as high as 90. 9% and 63. 4% respectively. Before chemotherapy,significant difference in ADC values existed between the two groups( P 〈0. 05). Preoperative ADC values had a negative relationship with the reduction of tumor size,while postoperative ADC values had a parallel relationship with the reduction of tumor size. Conclusion DWI has certain clinical value in assessing the therapeutic effect of chemoradiotherapy for nonsmall-cell lung cancer. The changes of ADC value can be used to monitor the early therapeutic response.
出处 《临床放射学杂志》 CSCD 北大核心 2014年第11期1670-1674,共5页 Journal of Clinical Radiology
关键词 磁共振成像 扩散加权成像 肺癌 放化疗 Magnetic resonance imaging Diffusion-weighted imaging Lung cancer Chemoradiotherapy
  • 相关文献

参考文献21

  • 1Weber WA. Assessing turner response to therapy. J Nucl Med ,2009, 50:1.
  • 2Wu LM, Xu JR, Hua J, et al. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nod- ules and masses? Magnetic Resonance Imaging,2013,31:235.
  • 3李伟栋,李东,刘海东,周荣超,冯长超,马艳,于铁链.3.0T MR扩散加权成像对肺实性良恶性病变的鉴别诊断效能及b值优化探讨[J].中国肺癌杂志,2011,14(11):853-857. 被引量:25
  • 4Afaq A, Akin O. Imaging assessment of tumor response : past, present and future. Future Oncology,2011,7 :669.
  • 5Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evalua- tion criteria in solid tumours : revised RECIST guideline ( version 1. 1 ). Eur J Cancer,2009,45:228.
  • 6Eradat J, Abtin F, Gutierrez A, et al. Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcino- ma. Cancer J, 2011,17:38.
  • 7Wenche M. Variation of magnetic resonance imaging and diffusion weighted imaging in pelvic lymgh node detection. European Journal of Radiology,2007,43:4323.
  • 8Naoki K,Hiroaki O. Role of diffusion-weighted magnetic resonance for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer. European journal of Cardio-thoracic Surgery,2009, 35:706.
  • 9Usuda K, Zhao XT, Sagawa M, et al. Diffusion-weighted imaging (DWI) signal intensity and distribution represent the amount of cancer cells and their distribution in primary lung cancer. Clinical Imaging ,2012,04 : 1010.
  • 10Kyriazi S, Collins DJ, Messiou C, et al. Metastatic ovarin and primary peritoneal cananer:assessing chemotherapy response with diffusion- weighted MRI-value of histogram analyisis of apparent diffusion coef- ficients. Radiology,2011,261 : 182.

二级参考文献29

  • 1孙应实,张晓鹏,唐磊.直肠癌扩散加权成像b值选取及其对直肠癌显示能力的评价[J].中国医学影像技术,2005,21(12):1839-1843. 被引量:44
  • 2Kapiteijn E,Marijnen CA,Nagtegaal ID,et al.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.N Engl J Med,2001,345:638-646.
  • 3Maiding AL,Holm T,Rutqvist LE,et al.Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm.Stockholm Colorectal Cancer Study Croup,Basingstoke Bowel Cancer Research Project Lancet,2000,356:93-96.
  • 4Folkesson J,Birgisson H,Pahlman L,et al.Swedish Rectal Cancer Trial:long lasting benefits from radiotherapy on survival and local recurrence rate.J Clin Oncol,2005,23:5644-5650.
  • 5Ortholan C,Francois E,Thomas O,et al.Role of radiotherapy with surgery for t3 and resectable t4 rectal cancer;evidence from randomized trials.Dis Colon Rectum,2006,49:302-310.
  • 6Allen SD,Padhani AR,Dzik-Jurasz AS,et al.Rectal carcinoma:MRI with histologic correlation before and after chemoradiation therapy.AJR,2007,188:442-451.
  • 7Dzik-Jurasz A,Domenig C,George M,et al.Diffusion MRI for prediction of response of rectal cancer to chemoradiation.Lancet,2002,360:307-308.
  • 8Kremser C,Judmaier W,Hein P,et al.Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging.Strahlenther Onkol,2003,179:641-649.
  • 9Greene FL,Page DL,Fleming ID,et al.AJCC cancer staging handbook.6 th ed New York:NY Springer Verlag,2002:113-123.
  • 10Berger C,de Muret A,Garaud P,et al.Preoperative radiotherapy(RT)for rectal cancer;predictive factors of tumor downstaging and residual tumor cell density(RTCD):prognostic implications.Int J Radiat Oncol Biol Phys,1997,37:619-627.

共引文献65

同被引文献89

  • 1陈忠平.脑转移瘤治疗观念的改变[J].中国神经肿瘤杂志,2004,2(3):155-158. 被引量:15
  • 2Siegel R,Ma J,Zou Z,et al. Cancer statistics, 2014[J]. CA Cancer J Clin,2014,64(1) :9-29.
  • 3Qiao P G, Zhang H T, Zhou J, et al. Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic con- trast-enhanced CT[J]. Clin Transl Oncol, 2 016,18 ( 1 ) : 4 7 - 5 7.
  • 4Okada H, Hontsu S, Miura S, et ah Changes of tumor size and tumor contrast enhancement during radiotherapy for non-small- cell lung cancer may be suggestive of treatment response[J]. J Ra diat Res,2012,53(2) :326-332.
  • 5Iwano S, Koike W, Matsuo K, et al. Correlation between dynam ic CT findings and pathological prognostic factors of small lung ad- enocarcinoma[J]. Cancer Imaging,2012,12(1) :187-193.
  • 6Knollmann F D,Rohan K,David F,et al. Assessing response to treatment in non-small cell lung cancer: role of tumor volume evaluated by computed tomography[J]. Clin Lung Cancer, 2014, 15 (2) :103-109.
  • 7Kim H, Park C M, Goo J M, et al. Quantitative computed tomo- graphy imaging hiomarkers in the diagnosis and management of lung cancer[J]. Invest Radiol, 2015,50 (9) : 571 - 583.
  • 8Qiao P G, Huang Q, Zhou J, et al. Feasibility of quantitative pa- rameters of dynamically enhanced patterns of spiral computed tomography scanning integrated into tumour progression before targeted treatment of non-small cell lung cancer[J]. J Med Ima ging Radiat Oncol,2015,59(2) :216-220.
  • 9Li X S, Fan H X, Fang H, et al. Value of whole-tumor dual in- put perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer[J]. AJR, 2014, 203(5): 497-505.
  • 10Zhao L, Guan W, Han Y, et al. Comparative study on CT per- fusion parameters of different types of lung cancer before and af- ter chemoradiotherapy[J]. J BioI Regul Homeost Agents, 2013, 28(4): 675-681.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部